Table Of ContentGET
THROUGH
MRCOG Part 2:
SBAs
GET
THROUGH
MRCOG Part 2:
SBAs
Rekha Wuntakal, MBBS, MD, DNB, MRCOG, DFFP
Consultant in Gynaecological Oncology and Gynaecology
Department of Obstetrics and Gynaecology, Queen’s Hospital
BHR University Hospitals NHS Trust, London
Madhavi Kalidindi, MRCOG
Consultant Obstetrician and Gynaecologist
Queen’s Hospital, BHR University Hospitals
NHS Trust, London
Tony Hollingworth, MB ChB, PhD, MBA, FRCS(Ed), FRCOG
Consultant in Obstetrics and Gynaecology
Whipps Cross Hospital, Barts Health NHS Trust
and
Senior Research Fellow
Centre for Cancer Prevention
Wolfson Institute of Preventive Medicine
QMUL, London
CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300
Boca Raton, FL 33487-2742
© 2018 by Taylor & Francis Group, LLC
CRC Press is an imprint of Taylor & Francis Group, an Informa business
No claim to original U.S. Government works
Printed on acid-free paper
International Standard Book Number-13: 978-1-4987-2401-2 (Paperback)
978-1-138-48212-8 (Hardback)
This book contains information obtained from authentic and highly regarded sources. While all reasonable efforts
have been made to publish reliable data and information, neither the author[s] nor the publisher can accept any
legal responsibility or liability for any errors or omissions that may be made. The publishers wish to make clear that
any views or opinions expressed in this book by individual editors, authors or contributors are personal to them
and do not necessarily reflect the views/opinions of the publishers. The information or guidance contained in this
book is intended for use by medical, scientific or health-care professionals and is provided strictly as a supplement
to the medical or other professional's own judgement, their knowledge of the patient's medical history, relevant
manufacturer's instructions and the appropriate best practice guidelines. Because of the rapid advances in medical
science, any information or advice on dosages, procedures or diagnoses should be independently verified. The reader
is strongly urged to consult the relevant national drug formulary and the drug companies’ and device or material
manufacturers’ printed instructions, and their websites, before administering or utilizing any of the drugs, devices
or materials mentioned in this book. This book does not indicate whether a particular treatment is appropriate or
suitable for a particular individual. Ultimately it is the sole responsibility of the medical professional to make his
or her own professional judgements, so as to advise and treat patients appropriately. The authors and publishers
have also attempted to trace the copyright holders of all material reproduced in this publication and apologize to
copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been
acknowledged please write and let us know so we may rectify in any future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted,
or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including
photocopying, microfilming, and recording, or in any information storage or retrieval system, without w ritten
permission from the publishers.
For permission to photocopy or use material electronically from this work, please access www.copyright.com
(http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive,
Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration
for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system
of payment has been arranged.
Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only
for identification and explanation without intent to infringe.
Library of Congress Cataloging-in-Publication Data
Names: Wuntakal, Rekha, author. | Kalidindi, Madhavi, author. | Hollingworth, Tony, author.
Title: Get through MRCOG Part 2 : SBAs / by Rekha Wuntakal, Madhavi Kalidindi
and Tony Hollingworth.
Description: Boca Raton, FL : CRC Press, [2018] | Includes bibliographical references and index.
Identifiers: LCCN 2018000007| ISBN 9781138482128 (hardback : alk. paper) |
ISBN 9781498724012 (paperback : alk. paper) | ISBN 9781351058612 (eBook)
Subjects: | MESH: Obstetrics | Gynecology | United Kingdom | Examination Questions
Classification: LCC RG111 | NLM WQ 18.2 | DDC 618.10076--dc23
LC record available at https://lccn.loc.gov/2018000007
Visit the Taylor & Francis Web site at
http://www.taylorandfrancis.com
and the CRC Press Web site at
http://www.crcpress.com
CONTENTS
1 Maternal medicine 1
Questions 1
Answers 8
2 Antenatal care 21
Questions 21
Answers 29
3 Postpartum problems (the puerperium) 43
Questions 43
Answers 47
4 Ethics and legal issues and consent 55
Questions 55
Answers 58
5 Medical statistics 63
Questions 63
Answers 66
6 Management of labour and delivery 71
Questions 71
Answers 77
7 Gynaecological oncology 87
Questions 87
Answers 92
8 Gynaecological problems 113
Questions 113
Answers 117
9 Contraception 137
Questions 137
Answers 141
v
C 10 Sexual and reproductive health 151
O
N Questions 151
T
E Answers 154
N
T
S 11 Genetic problems 165
Questions 165
Answers 168
12 Reproductive medicine or subfertility 177
Questions 177
Answers 180
13 Surgical procedures and core surgical skills 187
Questions 187
Answers 190
14 Post-operative complications 199
Questions 199
Answers 201
Index 205
vi
1
MATERNAL
MEDICINE
Questions
THYROID
1. A 36-year-old woman with known hypothyroidism has been taking
levothyroxine 100 micrograms once a day. Her most recent thyroid function
tests performed 3 months ago were normal with a thyrotropin (TSH) of
2.5 mU/L. She has come to the early pregnancy unit with abdominal pain and
a positive pregnancy test. Transvaginal ultrasound confirmed an intrauterine
pregnancy.
How would you advise with regards to her levothyroxine dosage?
a. Decrease dose to 75 micrograms per day
b. Decrease dose to 50 micrograms per day
c. No change required
d. Increase dose to 125 micrograms per day
e. Increase dose to 150 micrograms per day
2. A 25-year-old woman known to have hyperthyroidism is going for radioactive
iodine therapy. She has been trying to conceive for the last 6 months.
How long should she avoid pregnancy after this treatment?
a. 3 months
b. 6 months
c. 9 months
d. 12 months
e. 15 months
3. A 28-year-old para 1 woman at 40 weeks’ gestation delivered a baby with a
skin condition, diagnosed as ‘Aplasia cutis congenita’. She is known to have
hyperthyroidism secondary to Grave disease and has been on anti-thyroid
medication throughout the pregnancy.
Which one of the medications below is known to cause the above
condition?
a. Carbimazole
b. Hydrouracil
1
C c. Levothyroxine
h d. Methythiouracil
a
p e. Propylthiouracil
t
e
r
1
RENAL DISEASE IN PREGNANCY
M
A
T
E
R 4. A 38-year-old nulliparous woman with moderate chronic renal failure
N
A comes to the preconception clinic as she wishes to have a baby. She had
L
M renal transplantation 3 years ago and her recent creatinine is around 130
E with estimated glomerular filtration rate (GFR) of approximately 45. She
D
IC is currently taking prednisolone, mycophenolate, angiotensin-converting
IN enzyme (ACE) inhibitors and aspirin. You have advised her to stop
E
mycophenolate and to start another immunosuppressant.
Which one of the immunosuppressant drugs would be contraindicated in
pregnancy?
a. Azathioprine
b. Cyclosporine
c. Hydroxychloroquine
d. Sirolimus
e. Tacrolimus
5. A 25-year-old para 1 woman at 30 weeks’ gestation was brought in to the
Obstetric day assessment unit with abdominal and back pains, vomiting and
feeling unwell. Her observations are temperature 38.2°C, pulse 110 bpm, blood
pressure (BP) 100/60 mm Hg, respiratory rate 18/min and oxygen saturations
98% on room air. On examination, she has suprapubic and right flank
tenderness with 3+ leucocytes and positive nitrates on urine dipsticks. Foetal
movements were good and cardiotocography was normal. You have admitted
her and started broad spectrum intravenous antibiotics for acute pyelonephritis
after doing the septic screen.
What is the recurrence rate of pyelonephritis during the pregnancy?
a. 5%
b. 10%
c. 15%
d. 20%
e. 25%
RENAL TRANSPLANTATION
6. A 35-year-old nulliparous woman with chronic renal failure had a successful
renal transplantation surgery recently. She wishes to have children in the
future and her GP has referred for preconception advice.
What is the recommended time interval for conception after an allograft
transplantation?
a. 6 months
2
b. 12 months C
h
c. 18 months a
p
d. 24 months t
e
e. 30 months r 1
M
DERMATOLOGICAL CONDITIONS IN A
T
E
PREGNANCY R
N
A
L
Skin M
E
D
IC
7. A 28-year-old woman at 32 weeks’ gestation in her first pregnancy presented
IN
with a rash and itching on the abdomen, trunk, legs and hands. On E
examination, there were vesicles and bullae. A diagnosis of pemphigoid
gestationis was made by the dermatologists after skin biopsies.
Which one of the following statements is true about pemphigoid
gestationis?
a. Associated with other autoimmune diseases
b. Most common dermatosis of pregnancy
c. Not associated with any adverse effect on mother or foetus
d. Rash usually begins in the abdomen with periumbilical sparing
e. Recurrence in subsequent pregnancies is rare
8. A 30-year-old primigravida at 35 weeks’ gestation with monochorionic
diamniotic pregnancy presents with intense itching and rash on the abdomen.
On examination there were erythematous papules and plaques in the striae
gravidarum with umbilical sparing.
The most likely diagnosis is which one of the following?
a. Pemphigoid gestationis
b. Polymorphic eruption of pregnancy
c. Atopic eruption of pregnancy
d. Prurigo of pregnancy
e. Pruritic folliculitis of pregnancy
GASTROINTESTINAL TRACT (GIT) AND LIVER
9. A 34-year-old woman at 36 weeks’ gestation was admitted with feeling
unwell, vomiting and right-sided upper abdominal pain. On examination
she was tender in the right upper quadrant with BP 140/90 mm Hg, pulse
90 bpm, temperature 37.6°C and protein 1+ in the urine. Her Hb was 128 g/L,
platelets 160, white blood cell (WBC) count was elevated at 18, liver function
was deranged with hyperbilirubinaemia and moderately raised alanine
aminotransferase (ALT) and aspartate aminotransferase (AST). She was
hypoglycaemic and clotting was mildly deranged with prolonged prothrombin
time (PT) and activated partial thromboplastin time (aPTT). Renal function
and liver scan were normal.
3
